Achillion Pharmaceuticals CEO Michael Kishbauch receives $847K in 2006
Achillion Pharmaceuticals reports 2006 executive compensation
By ExecPay News
Published: April 30, 2007
Achillion Pharmaceuticals reported fiscal year 2006 executive compensation information on April 30, 2007.
In 2006, five executives at Achillion Pharmaceuticals received on average a compensation package of $435K.
Average pay of disclosed executives at Achillion Pharmaceuticals
Michael Kishbauch, Chief Executive Officer, received $847K in total. 40% of Kishbauch's compensation, or $341K, was in salary. Kishbauch also received $170K in non-equity incentive plan, $335K in option awards, as well as $281 in other compensation.
John Pottage, Chief Medical Officer, received a compensation package of $365K. 68% of the compensation package, or $249K, was in salary.
Milind Deshpande, Chief Scientific Officer, earned $353K in 2006.
Gautam Shah, Senior Vice President and Chief Compliance Officer, received $339K in 2006.
Mary Kay Fenton, Chief Financial Officer, earned $271K in 2006.
Related executives
Michael Kishbauch
Achillion Pharmaceuticals
Chief Executive Officer
Mary Fenton
Achillion Pharmaceuticals
Chief Financial Officer
Milind Deshpande
Achillion Pharmaceuticals
Chief Executive Officer
Gautam Shah
Achillion Pharmaceuticals
Former Executive Vice President and Chief Compliance Officer
John Pottage
Achillion Pharmaceuticals
Chief Medical Officer
You may also like
Source: SEC filing on April 30, 2007.